XML 55 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
CASH FLOWS FROM OPERATING ACTIVITIES      
Net loss $ (56,085) $ (15,519) $ (9,596)
Adjustments to reconcile net loss to net cash provided by operating activities:      
Non-cash revenue (541) (1,062) (4,608)
Depreciation and amortization 4,007 3,978 4,632
Amortization of deferred television production costs 7,457 23,964 27,269
Impairment charge 44,257 0 0
Other-than-temporary loss on cost-based investments 88 2,724 0
Non-cash equity compensation 3,939 5,020 5,400
Deferred income tax expense 1,243 1,347 1,327
Income on equity securities 0 (15) 15
Gain on sale of short-term investments 0 0 (1,512)
Gain on sales of cost-based investments (1,165) (7,647) 0
Loss on sale of fixed asset 0 0 647
Other non-cash charges, net 224 1,907 563
Changes in operating assets and liabilities      
Accounts receivable, net 10,164 11,013 (711)
Paper inventory 2,645 (1,916) (143)
Deferred television production costs (7,891) (21,395) (25,894)
Accounts payable and accrued liabilities and other (10,981) (6,292) 4,969
Accrued payroll and related costs 2,308 467 (954)
Deferred subscription revenue (2,347) (3,270) (996)
Deferred revenue (221) 2,241 (484)
Other changes 3,138 2,235 1,948
Total changes in operating assets and liabilities (3,185) (16,917) (22,265)
Net cash provided by / (used in) operating activities 239 (2,220) 1,872
CASH FLOWS FROM INVESTING ACTIVITIES      
Capital expenditures (1,314) (2,879) (4,707)
Proceeds from the sale of fixed assets 0 0 1,403
Purchases of short-term investments (38,113) (8,414) (15,345)
Sales of short-term investments 19,344 7,179 18,802
Proceeds from the sales of cost-based investments 1,165 11,000 0
Investment in other non-current assets 0 0 0
Net cash used in investing activities (18,918) 6,886 153
CASH FLOWS FROM FINANCING ACTIVITIES      
Repayment of long-term debt 0 (9,000) (4,500)
Dividends paid (2) (16,722) 0
Proceeds from equity sale, net of expenses 0 34,593 0
Proceeds received from stock option exercises 153 1,712 295
Net cash provided by / (used in) financing activities 151 10,583 (4,205)
Net decrease in cash (18,528) 15,249 (2,180)
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD 38,453 23,204 25,384
CASH AND CASH EQUIVALENTS, END OF PERIOD $ 19,925 $ 38,453 $ 23,204